Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PSME3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC101927849 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRNB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRTP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAMTA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YBEY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCAPG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRNT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCMDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC728730 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR2M4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIGLEC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FENDRR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRTG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on